SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health Sciences Authority (HSA) for its…
Objective response rate (ORR) of 83% including two complete responses in CLL patients in Phase 1a study with median progression…
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to…
Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or…
Company brings its Scientific Activation™ mission to life at ASH Annual Meeting following November rebrand RESTON, Va., Dec. 5, 2025 /PRNewswire/…
Atropos Health is integrating the American Society of Clinical Oncology® (ASCO®) Guidelines into their platform and presenting rare disease AI…
PLANO, Texas, Dec. 5, 2025 /PRNewswire/ -- Teams playing in the StaffDNA® Cure Bowl were announced today for the matchup…
IRVINE, Calif., Dec. 5, 2025 /PRNewswire/ -- The Dot Corp, a leader in high quality print, kitting, assembly, and fulfillment for…
Concludes Distribution Agreement with Gore® for VIABIL® in the United States and Canada, Effective January 1, 2026 Announces Intent to…
COLUMBUS, Ohio and NEW YORK, Dec. 4, 2025 /PRNewswire/ -- Paradigm Health, the technology company rebuilding the clinical research ecosystem,…